Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Unstable Angina Pectoris · Gastric Carcinoma · COLL

COLLEGIUM PHARMACEUTICAL

COLLEGIUM PHARMACEUTICAL, INC

COLLEGIUM PHARMACEUTICAL patent portfolio — 28 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
100 Technology Center Dr, Stoughton, Massachusetts 02072, US HQ
617 Employees
Public company Type
COLL · NYSE Ticker
Company details
Status
Public
HQ
100 Technology Center Dr, Stoughton, Massachusetts 02072, US
Employees
617
Programs
29
Drugs
48
Patents
28
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

COLLEGIUM PHARMACEUTICAL patents

28 pharmaceutical patents indexed for COLLEGIUM PHARMACEUTICAL. 1 expire within 24 months.

COLLEGIUM PHARMACEUTICAL has 28 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

28 patents

Patent portfolio

  1. US 11191758

    Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10668060

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10525052

    Abuse-deterrent drug formulations

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10525053

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9763883

    Abuse-deterrent drug formulations

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9737530

    Process of making stable abuse-deterrent oral formulations

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9682075

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9592200

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9248195

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9044398

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8840928

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8758813

    Abuse-deterrent drug formulations

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8557291

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8512751

    Pharmaceutical compositions for sleep disorders

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8449909

    Abuse-deterrent drug formulations

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8021687

    Modified release compositions of milnacipran

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7771707

    Abuse-deterrent drug formulations

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7704527

    Modified release compositions of milnacipran

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7585520

    Compositions containing both sedative and non-sedative antihistamines and sleep aids

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7399488

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7387792

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7038085

    Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof

    Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6863901

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6827946

    Compositions containing both sedative and non-sedative antihistamines

    Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does COLLEGIUM PHARMACEUTICAL have?

28 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do COLLEGIUM PHARMACEUTICAL patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.